270 related articles for article (PubMed ID: 16255046)
1. The effectiveness of treating juvenile dermatomyositis with methotrexate and aggressively tapered corticosteroids.
Ramanan AV; Campbell-Webster N; Ota S; Parker S; Tran D; Tyrrell PN; Cameron B; Spiegel L; Schneider R; Laxer RM; Silverman ED; Feldman BM
Arthritis Rheum; 2005 Nov; 52(11):3570-8. PubMed ID: 16255046
[TBL] [Abstract][Full Text] [Related]
2. Medium- and long-term functional outcomes in a multicenter cohort of children with juvenile dermatomyositis.
Huber AM; Lang B; LeBlanc CM; Birdi N; Bolaria RK; Malleson P; MacNeil I; Momy JA; Avery G; Feldman BM
Arthritis Rheum; 2000 Mar; 43(3):541-9. PubMed ID: 10728746
[TBL] [Abstract][Full Text] [Related]
3. Rituximab as therapy for refractory polymyositis and dermatomyositis.
Noss EH; Hausner-Sypek DL; Weinblatt ME
J Rheumatol; 2006 May; 33(5):1021-6. PubMed ID: 16541475
[TBL] [Abstract][Full Text] [Related]
4. Corticosteroid sparing effect of low dose methotrexate treatment in adult Still's disease.
Fautrel B; Borget C; Rozenberg S; Meyer O; Le Loët X; Masson C; Koeger AC; Kahn MF; Bourgeois P
J Rheumatol; 1999 Feb; 26(2):373-8. PubMed ID: 9972972
[TBL] [Abstract][Full Text] [Related]
5. Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: a comparative study.
Ross HJ; Gullestad L; Pak J; Slauson S; Valantine HA; Hunt SA
J Heart Lung Transplant; 1997 Feb; 16(2):179-89. PubMed ID: 9059929
[TBL] [Abstract][Full Text] [Related]
6. Treatment of early seropositive rheumatoid arthritis: doxycycline plus methotrexate versus methotrexate alone.
O'Dell JR; Elliott JR; Mallek JA; Mikuls TR; Weaver CA; Glickstein S; Blakely KM; Hausch R; Leff RD
Arthritis Rheum; 2006 Feb; 54(2):621-7. PubMed ID: 16447240
[TBL] [Abstract][Full Text] [Related]
7. Long-term observational study of sporadic inclusion body myositis.
Benveniste O; Guiguet M; Freebody J; Dubourg O; Squier W; Maisonobe T; Stojkovic T; Leite MI; Allenbach Y; Herson S; Brady S; Eymard B; Hilton-Jones D
Brain; 2011 Nov; 134(Pt 11):3176-84. PubMed ID: 21994327
[TBL] [Abstract][Full Text] [Related]
8. Methotrexate improves the health-related quality of life of children with juvenile idiopathic arthritis.
Céspedes-Cruz A; Gutiérrez-Suárez R; Pistorio A; Ravelli A; Loy A; Murray KJ; Gerloni V; Wulffraat N; Oliveira S; Walsh J; Penades IC; Alpigiani MG; Lahdenne P; Saad-Magalhães C; Cortis E; Lepore L; Kimura Y; Wouters C; Martini A; Ruperto N;
Ann Rheum Dis; 2008 Mar; 67(3):309-14. PubMed ID: 17875547
[TBL] [Abstract][Full Text] [Related]
9. Methotrexate, hydroxychloroquine, and intramuscular gold in rheumatoid arthritis: relative area under the curve effectiveness and sequence effects.
Hurst S; Kallan MJ; Wolfe FJ; Fries JF; Albert DA
J Rheumatol; 2002 Aug; 29(8):1639-45. PubMed ID: 12180722
[TBL] [Abstract][Full Text] [Related]
10. Longterm combination therapy of refractory and destructive rheumatoid arthritis with methotrexate (MTX) and intramuscular gold or other disease modifying antirheumatic drugs compared to MTX monotherapy.
Rau R; Schleusser B; Herborn G; Karger T
J Rheumatol; 1998 Aug; 25(8):1485-92. PubMed ID: 9712088
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of methotrexate in recalcitrant cutaneous lupus erythematosus: results of a retrospective study in 43 patients.
Wenzel J; Brähler S; Bauer R; Bieber T; Tüting T
Br J Dermatol; 2005 Jul; 153(1):157-62. PubMed ID: 16029342
[TBL] [Abstract][Full Text] [Related]
12. Methotrexate is an effective treatment for chronic uveitis associated with juvenile idiopathic arthritis.
Foeldvari I; Wierk A
J Rheumatol; 2005 Feb; 32(2):362-5. PubMed ID: 15693100
[TBL] [Abstract][Full Text] [Related]
13. The magnitude of early response to methotrexate therapy predicts long-term outcome of patients with juvenile idiopathic arthritis.
Bartoli M; Tarò M; Magni-Manzoni S; Pistorio A; Traverso F; Viola S; Magnani A; Gasparini C; Martini A; Ravelli A
Ann Rheum Dis; 2008 Mar; 67(3):370-4. PubMed ID: 17660217
[TBL] [Abstract][Full Text] [Related]
14. Treatment of non-life threatening Wegener's granulomatosis with methotrexate and daily prednisone as the initial therapy of choice.
Stone JH; Tun W; Hellman DB
J Rheumatol; 1999 May; 26(5):1134-9. PubMed ID: 10332980
[TBL] [Abstract][Full Text] [Related]
15. Dose escalation of parenteral methotrexate in active rheumatoid arthritis that has been unresponsive to conventional doses of methotrexate: a randomized, controlled trial.
Lambert CM; Sandhu S; Lochhead A; Hurst NP; McRorie E; Dhillon V
Arthritis Rheum; 2004 Feb; 50(2):364-71. PubMed ID: 14872477
[TBL] [Abstract][Full Text] [Related]
16. Adjunctive methotrexate for treatment of giant cell arteritis: an individual patient data meta-analysis.
Mahr AD; Jover JA; Spiera RF; Hernández-García C; Fernández-Gutiérrez B; Lavalley MP; Merkel PA
Arthritis Rheum; 2007 Aug; 56(8):2789-97. PubMed ID: 17665429
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic approaches in the treatment of juvenile dermatomyositis in patients with recent-onset disease and in those experiencing disease flare: an international multicenter PRINTO study.
Hasija R; Pistorio A; Ravelli A; Demirkaya E; Khubchandani R; Guseinova D; Malattia C; Canhao H; Harel L; Foell D; Wouters C; De Cunto C; Huemer C; Kimura Y; Mangge H; Minetti C; Nordal EB; Philippet P; Garozzo R; Martini A; Ruperto N;
Arthritis Rheum; 2011 Oct; 63(10):3142-52. PubMed ID: 21647864
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness, side-effects and period of remission after treatment with methotrexate in localized scleroderma and related sclerotic skin diseases: an inception cohort study.
Kroft EB; Creemers MC; van den Hoogen FH; Boezeman JB; de Jong EM
Br J Dermatol; 2009 May; 160(5):1075-82. PubMed ID: 19210503
[TBL] [Abstract][Full Text] [Related]
19. A randomized trial of parenteral methotrexate comparing an intermediate dose with a higher dose in children with juvenile idiopathic arthritis who failed to respond to standard doses of methotrexate.
Ruperto N; Murray KJ; Gerloni V; Wulffraat N; de Oliveira SK; Falcini F; Dolezalova P; Alessio M; Burgos-Vargas R; Corona F; Vesely R; Foster H; Davidson J; Zulian F; Asplin L; Baildam E; Consuegra JG; Ozdogan H; Saurenmann R; Joos R; Pistorio A; Woo P; Martini A;
Arthritis Rheum; 2004 Jul; 50(7):2191-201. PubMed ID: 15248217
[TBL] [Abstract][Full Text] [Related]
20. Randomized trial of cyclophosphamide versus methotrexate for induction of remission in early systemic antineutrophil cytoplasmic antibody-associated vasculitis.
De Groot K; Rasmussen N; Bacon PA; Tervaert JW; Feighery C; Gregorini G; Gross WL; Luqmani R; Jayne DR
Arthritis Rheum; 2005 Aug; 52(8):2461-9. PubMed ID: 16052573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
